https://doi.org/10.1101/407890 doi: bioRxiv preprint environmental and genetic perturbations in patients, supporting the heterogeneous nature of 72 SZ. Higher PRS for SZ was associated with thinner fronto-temporal cortices and smaller 73 subcortical volumes, but there were no significant associations with the heterogeneity in these 74 measures, i.e. the variability among individuals with high PRS were comparable to the 75 variability among individuals with low PRS. This suggests that brain variability in SZ results 76 from interactions between environmental and genetic factors that are not captured by the 77 PGR. Factors contributing to heterogeneity in fronto-temporal cortices and hippocampus are 78 thus key to further our understanding of how genetic and environmental factors shape brain 79 biology in SZ. 80
Introduction 81 Schizophrenia (SZ) is a severe psychiatric disorder with a lifetime prevalence of about 1%, 82 rendering it a leading cause of disability worldwide with 26 million people affected 1 . While 83 genetic and environmental factors contributing to disease risk have been identified, the 84 pathophysiology still remains elusive 2,3 . Patients diagnosed with SZ display substantial 85 heterogeneity in terms of their clinical characteristics and symptoms 4 , treatment response 5 and 86 long term prognosis 6 . The notion that the observed heterogeneity stems at least partially from 87 distinct subtypes of patients with differentially affected neurobiology and clinical and 88 cognitive profiles 7-9 , has not been fully confirmed 10 , and the question of whether there is one 89 unifying pathophysiological process shared across patients, or a multitude of disease 90 processes leading to a similar clinical syndrome remains salient 11 . 91 SZ is associated with widespread brain abnormalities, with the most robust group-92 level mean structural differences being ventricle enlargement, reduced thickness and area of 93 frontal and temporal cortices, as well as reduced hippocampal and amygdala volumes 12-14 . 94 However there is also substantial variability between patients 7,8,15,16 , presenting a major 95 challenge for achieving imaging based diagnostic predictions with any clinical utility 17, 18 . 96
Rather than simply reflecting noise, this inter-individual variability in brain structure may 97 possibly carry relevant information regarding gene-environment interactions related to the 98 individual sensitivity to environmental and genetic perturbation. Only a few studies have 99 investigated whether heterogeneity differs between healthy participants and SZ patients. One 100 functional imaging study reported increased heterogeneity in both connectivity and spatial 101 extent of functional brain networks in SZ 19 . Regions with altered spatial variance in functional 102 networks included areas previously implicated in SZ, such as auditory and sensorimotor 103 cortices and basal ganglia, and networks showing increased heterogeneity overlapped with 104 those showing mean volume differences, implying that the mean and variance measures 105 provide complementary but converging results 20 . A recent meta-analysis reported increased 106 inter-individual volumetric variability in several cortical and subcortical structures, including 107 the temporal lobe, thalamus, hippocampus and amygdala in SZ, and lower variability in the 108 anterior cingulate cortex (ACC) 15 . These results point to the importance of modeling 109 heterogeneity as well as mean changes. Detecting brain regions that are more homogenous in 110 patients could point to a primary role in a shared underlying SZ pathophysiology, while 111 regions of increased heterogeneity might be informative of putative subtypes of disease, or 112 possibly reflect regional differences in the sensitivity to genetic and environmental 113 perturbations. 114 SZ is highly heritable 21 , motivating the ongoing efforts to identify intermediate brain 115
phenotypes associated with disease liability in order to elucidate the pathway from genes to 116 illness manifestation. Several SZ risk loci have been identified 22 , but the individual 117 contribution of each identified variant is weak and as of yet no common variants have been 118 conclusively linked to the disease. Polygenic risk scores (PRS) for SZ, which represent a 119 weighted sum of common genetic SZ risk alleles, have been proposed to account for the 120 polygenic nature of disease risk and to increase predictive power 23 . Beyond being predictive 121 of case-control status 22 , SZ PRS have been associated with negative symptoms, anxiety and 122 lower cognitive ability in adolescents 24 . Polygenic burden has also been linked to reduced 123 cortical thickness, as well as with prefrontal working memory-, and hippocampal encoding-124 related activation and connectivity in both patients and healthy participants 25-28 . This is in line 125 with findings implicating both the frontal cortices and hippocampus as core regions in SZ 126 pathophysiology 29 . Polygenic risk for SZ is however only weakly associated with subcortical 127 volumes 30 . Importantly, risk alleles could also exert their effect by influencing the 128 environmental sensitivity, which could be reflected in the phenotypic variability between 129 individuals 31 . 130 variability is associated with the cumulative polygenic risk for SZ, we tested for associations 140 between dispersion in the same brain features and PGR for SZ in 12,490 healthy individuals 141 from the UK Biobank. 142 143
Material and methods 144
Samples: Sample characteristics are presented in Table 1 22 . The scores were calculated at a range of p-value 156 thresholds, from 0.001 to 0.5, with intervals of 0.001 (eMethods: Genetics). PRS based on a 157 threshold of .05 were used for the main analysis since this threshold has been reported as 158 optimal in terms of explaining case-control differences 40 , but we also performed follow-up 159 analysis to test the robustness of findings to threshold selection. 160
161

Statistical analysis 162
Statistical analyses were performed in R (3.2.2; https://www.r-project.org/) and MATLAB 163 (2014a, The MathWorks, Inc., Natick, Massachusetts, United States). For all included 164 measures in the multi-scanner case-control sample we used vertex/volume-wise generalized 165 additive models (GAM, R-Package: mgcv 41 ) to regress out scanner effects while accounting 166 for age, sex and diagnosis. We then modeled vertex/volume-wise mean and dispersion effects 167 using double generalized linear models (DGLMs), which iteratively fits a GLM modeling the 168 mean parameter, and a second GLM modeling the dispersion parameter (eMethods: DGLMs; 169 R-package: dglm 42 ). We then permuted the SZ and PRS column vector, respectively, and 170 recalculated the mean and dispersion effects. For cortical thickness the true test statistics and 171 the permuted statistical maps where then submitted to PALM 43 to correct for multiple 172 comparisons using threshold-free cluster enhancement (TFCE) and tail approximation 47 (600 173 permutations: eMethods: Permutation). Maps were thresholded at a significance level of 174 p<.05. For the cortical, subcortical, and hippocampal subfields volumes we performed 5000 175 permutations per volume and extracted the maximum t-value across ROIs when computing p-176 values in order to correct for multiple comparisons. Significance threshold was set at p<.05. 177
We also performed a meta-analysis of the multi-scanner thickness data (R-Package: 178 metafor 44 ) estimating case-control difference within each sample, and conducted analyses 179 both with and without covarying for estimated intracranial volume (eTIV) for the volumetric 180 measures. We performed follow-up analyses with more stringent exclusion criteria 181 (eMethods: Outliers). To assess the effect of PRS p-threshold selection, we performed a 182 principal component analysis (R-package: prcomp, factoextra 45 ) on PRS scores calculated 183 across several thresholds (eMethods: PRS-PCA), and reran cortical thickness analysis on 184 PCA-scores. 185
186
Results 187
Vertex-wise thickness: SZ was associated with decreased mean thickness globally, with the 188 exception of the visual cortex, as well as globally increased thickness dispersion (Figure 1 Cortical and subcortical volumes: SZ was associated with lower mean cortical volume, 206 supratentorial volume, total and subcortical gray volume, cerebellar cortical volume, as well 207 as brain stem, hippocampus, amygdala, thalamus and nucleus accumbens, and several white 208 matter volumes, as well as increased ventricle, caudate nucleus, pallidum and putamen 209 volumes. SZ was further associated with increased dispersion in mean cortical volume, total 210 gray volume, left hippocampus and ventricle volumes ( Figure 2B , Figure 3 ). Models without 211 eTIV (eFigure 7A) revealed no significant differences in the mean volumes of caudate 212 nucleus and left putamen, and resulted in an additional significant association with dispersion 213 in supratentorial volume. Reanalysis of mean and dispersion models with more stringent 214 exclusion criteria showed converging results (eTable 2). PGR was not associated with mean 215 or dispersion in any of the subcortical volumes ( Figure 3B ), this was also true for models 216 without adjustment for eTIV (eFigure 7B). 217
218
Hippocampal subfields: Patients with SZ was associated with lower mean volume in both left 219 and right whole hippocampus as well as in all hippocampal subfields, accompanied with 220 larger right hippocampal fissures. There was increased dispersion in SZ in left whole 221 hippocampus, as well as in left molecular layer, left granule cell layer of the dentate gyrus 222 (GC-DG) and left CA4 ( Figure 4A ). Models without adjustment for eTIV gave the same 223 results for mean volumes with the exception for left hippocampal fissure, which did not 224 survive correction. Additional dispersion effects were observed for right whole hippocampus, 225 and left CA1 (eFigure 8A). When reanalyzing SZ mean and dispersion models with more 226 stringent exclusion criteria, we obtained similar results (eTable 3). PGR was associated with 227 smaller left CA2/3. None of the subfields showed an association between volume dispersion 228 and PRS ( Figure 4B ). Models without adjustment for eTIV revealed smaller left and right 229 CA2/3, left granule cell layer of the dentate gyrus (GC-DG), and left CA4 (eFigure 8B) in 230 patients with SZ. Re-analysis with population covariates added to the models, re-analysis with 231 stricter exclusion criteria, and modeling PRS using the first principal component, did not alter 232 conclusions (eTable 4). 233
234
Discussion 235
In the current study we found that SZ is associated with increased brain heterogeneity in 236 cortical thickness, as well as in cortical volumes, lateral and third ventricles and hippocampal 237 volumes. The findings, based on harmonized analysis protocols for all included datasets, were 238 robust to strict procedures for removing outliers, and follow-up meta-analysis confirmed that 239 multi-site case-control difference cannot be explained by scanning site. These findings are 240 largely in line with a recent meta-analytic study showing increased volumetric heterogeneity 241 in the temporal lobe and lateral and third ventricles 15 . It also extends this meta-analysis by 242
showing increased heterogeneity in cortical thickness as well as in specific hippocampal 243 subfields. Further, increased polygenic risk in healthy individuals was associated with 244 reductions in thickness in frontal and temporal regions, as well as in left dentate gyrus and 245 CA4 and bilateral CA2/3, but not related to thickness dispersion. 246
We found widespread reductions in cortical thickness in SZ patients, with the 247 characteristic pattern of stronger fronto-temporal effects, as well as global reductions in 248 cortical volume 46 . In addition to these mean changes, we found that SZ is also associated with 249 increased thickness heterogeneity compared to healthy controls. No cortical region showed 250 the opposite pattern of increased homogeneity among patients. As with previous studies we 251 found mean reductions in several brain volumes, with the most robust effects for cortical 252 volume, cerebellum and hippocampus, as well as ventricle enlargement. These regions 253 additionally showed increased heterogeneity in patients compared to controls, and again no 254 region showed increased homogeneity, as might result if a particular region was similarly 255 affected by a common pathophysiological mechanism 15 . Instead, the results are in line with 256 previous studies suggesting substantial neurobiological heterogeneity in SZ 16 . They do 257 however contrast with a recent report 15 of increased volumetric homogeneity in SZ. One 258 possible explanation is differing sample inclusion criteria, as the previous study included only 259 first-episode psychosis patients. It is not unlikely that an earlier disease stage may offer a 260 more direct window into core aspects of the pathophysiology which later shift towards 261 increased inter-individual variability as patients vary across different illness stages and 262 degrees of severity, as well as differences in treatment and medication status. 263 PRS reflect cumulative risk across multiple genetic loci, and SZ PRS is associated 264 with several phenotypic traits, including liability for psychiatric disease such as bipolar 265 disorder and schizoaffective disorder, negative symptoms, as well as IQ, working memory 266 performance and brain activation 25,47,48 . SZ-PRS has been associated with cortical gyrification 267 in healthy participants 49 , as well as reductions in global cortical thickness 27 . The current 268 results show that higher SZ-PRS in healthy participants are associated with mean decrease in 269 thickness in fronto-temporal cortices. Interestingly, these shifts in mean thickness were not 270 associated with changes in brain heterogeneity, as was found for patients, pointing to 271 differential effects of genetic risk on mean and heterogeneity changes. A recent study found 272 that SZ environmental risk scores and SZ-PRS scores are both independently related to 273 frontotemporal cortical thinning in patients, but not controls 27 . This underscores the 274 importance of also investigating environmental risk factors, as well as gene-environment 275 interplay, and their role in explaining the observed clinical and neurobiological heterogeneity 276
With regard to hippocampal volumes, we found that higher polygenic risk was 277 associated with smaller volumes of the left CA2/3, in the absence of an effect on total 278 hippocampal volume and after correcting for total intracranial volume, suggesting a specific 279 effect of genetic risk on this region. The hippocampus has been hypothesized to play a 280 primary role in the pathophysiology of SZ, through progressive changes to its neural circuits 281 as the disease evolves 29 . Our results also complement recent studies reporting that polygenic 282 risk for SZ is predictive of hippocampal activation during memory encoding 28 , and of 283 polygenic overlap between SZ and hippocampus volume 50 . Also, while the patients showed 284 increased hippocampal heterogeneity, only mean effects were associated with PRS, mirroring 285 the findings on cortical thickness. Thus, the dentate gyrus and CA2/3 emerge as key regions 286 both for the manifestation of, and the genetic risk for, SZ and potentially informative for the 287 classification of sub-types and degrees of severity. 288
Despite reliable associations between SZ and brain morphometry 14 , PRS is only 289 weakly associated with subcortical volumes, however a recent study found polygenic overlap 290 for SZ and hippocampal, putamen and intracranial volumes 50 . The lack of associations 291 between PRS and subcortical volumes in the current study is in line with most previous 292 reports or PRS 30 . 293
294
Limitations 295
An important source of heterogeneity in the present case-control sample could be the large 296 number of different scanning-sites included. However, in addition to residualizing for 297 scanner-site in the main analysis, we also performed within-sample analysis and ran meta-298 analysis, which rule out scanner as a major contributor to the observed effects. Heterogeneity 299 could be associated with differences in medication status and duration of illness. While we 300 did find increased caudate and putamen volumes, indicative of medication effects 51 , these 301 volumes did not show altered heterogeneity in SZ. Still, antipsychotic medication could 302 possibly affect brain heterogeneity in other regions, in absence of a change in mean volume. 303
Investigation of such effects requires carefully controlled settings, and is therefore difficult to 304 address in large-scale multi-site studies. Another possible explanation is that the increased 305 variability is caused by movement artefacts, which are typically greater in clinical 306 populations 52 , however running the analysis in a subset with stricter criteria for dataset 307 exclusion did not alter the conclusions. One important consideration for case-control studies 308 in general is the possibility that healthy controls are abnormally normal compared to the 309 general healthy population due to selection bias and strict exclusion criteria 53 , underscoring 310 the importance of studying the full range of phenotypic variability in the population. Further, 311 the validity of choosing a given p-threshold selection among several possible thresholds when 312 calculating PRS is uncertain. We addressed this by performing follow-up analysis where we 313 performed PCA across PRS calculated across a wide range of thresholds, to derive a more 314 general score of polygenic risk. This approach yielded results converging with the main 315 analysis using a threshold of p < .05. The lack of association between SZ-PRS and brain 316 heterogeneity suggest that the current SZ-PRS scores do not strongly reflect variance-317 controlling variants. As a composite score, SZ-PRS likely also hides a substantial genetic 318 heterogeneity. A PRS-score calculated using a variance-controlling trait loci (vQTL) 319 approach would likely be more sensitive in detecting such effects. Lastly, SZ is increasingly 320 understood as a neurodevelopmental disorder 54 There are ongoing efforts to account for brain heterogeneity by means of delineating patient 326 subtypes 8,55 , as well as characterizing patients by their differential degree of affectedness 327 along one or multiple symptom-axes 11,56 . Here we report that SZ is associated with 328 widespread and increased heterogeneity in cortical thickness, and cortical as well as 329 hippocampal volume, beyond the known mean differences, compared controls. The results 330 support to the notion that SZ is a highly heterogeneous disorder, and suggests that important 331 information may be overlooked when only assessing mean differences. In healthy adults SZ-332 PRS were associated with mean changes in brain areas implicated in SZ, but not associated 333 with altered brain heterogeneity. WHO. The Global Burden with an increase of the hippocampal fissures. Hippocampal volumes were also more 565 heterogeneous in the SZ-group, and among the subfields this effect was present in the left 566 molecular layer, bilateral CA1, right dentate gyrus and left CA4. B: Polygenic risk for SZ was 567 associated with mean reductions of left dentate gyrus, left CA4 and bilateral CA2/3. Neither 568 total hippocampal volumes nor any of the subfields showed a significant association between 569 polygenic risk and volume heterogeneity. 570 572   S  a  m  p  l  e  n  m  e  a  n  a  g  e  s  t  d  f  e  m  a  l  e  s  (  n  )  n  m  e  a  n  a  g  e  s  t  d  f  e  m  a  l  e  s  (  n  )   B  r  a  i  n  G  l  u  S  c  h  i  4  7  3  3  ,  7  1  2  ,  7  1  8  3  7  3  7  ,  2  1  5  ,  3  3  C  I  M  H  4  3  3  0  ,  6  1  1  ,  5  1  4  5  3  3  1  ,  2  8  ,  6  1  7  C  N  P  -1  1  0  2  3  1  ,  7  8  ,  9  4  7  2  5  3  6  ,  9  9  ,  3  8  C  P  N  -1  2  3  3  0  ,  7  8  ,  6  1  2  2  5  3  6  ,  0  8  ,  6  4  C  O  B  R  E  9  0  3  8  ,  1  1  1  ,  7  2  6  8  8  3  8  ,  1  1  3  ,  7  1  8  H  U  B  I  N  1  0  2  4  2  ,  0  8  ,  8  3  3  9  4  4 showing explained variance for the first 10 components. B: Cross-correlation matrix of first 583 four MDS components, first five principal components, and PRS for thresholds from .001 to 584
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suggesting that the results from the main analysis are not driven by site-related variance not accounted for in the multi-site regression models. 615
The analysis also included removal of subjects with either eTIV or mean thickness-values at | z | > 3, or significant outlier test (corrected p < .05). 616
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